Brown Adam J, Teng Zhongzhao, Calvert Patrick A, Rajani Nikil K, Hennessy Orla, Nerlekar Nitesh, Obaid Daniel R, Costopoulos Charis, Huang Yuan, Hoole Stephen P, Goddard Martin, West Nick E J, Gillard Jonathan H, Bennett Martin R
From the Division of Cardiovascular Medicine (A.J.B., P.A.C., N.K.R., O.H., D.R.O., C.C., M.R.B.), Department of Radiology (Z.T., Y.H., J.H.G.), and Department of Engineering (Z.T.), University of Cambridge, United Kingdom; MonashHEART, Monash Medical Centre, Clayton, Australia (N.N.); and Department of Interventional Cardiology (P.A.C., S.P.H., N.E.J.W.) and Department of Pathology (M.G.), Papworth Hospital NHS Trust, United Kingdom.
Circ Cardiovasc Imaging. 2016 Jun;9(6). doi: 10.1161/CIRCIMAGING.115.004172.
Although plaque rupture is responsible for most myocardial infarctions, few high-risk plaques identified by intracoronary imaging actually result in future major adverse cardiovascular events (MACE). Nonimaging markers of individual plaque behavior are therefore required. Rupture occurs when plaque structural stress (PSS) exceeds material strength. We therefore assessed whether PSS could predict future MACE in high-risk nonculprit lesions identified on virtual-histology intravascular ultrasound.
Baseline nonculprit lesion features associated with MACE during long-term follow-up (median: 1115 days) were determined in 170 patients undergoing 3-vessel virtual-histology intravascular ultrasound. MACE was associated with plaque burden ≥70% (hazard ratio: 8.6; 95% confidence interval, 2.5-30.6; P<0.001) and minimal luminal area ≤4 mm(2) (hazard ratio: 6.6; 95% confidence interval, 2.1-20.1; P=0.036), although absolute event rates for high-risk lesions remained <10%. PSS derived from virtual-histology intravascular ultrasound was subsequently estimated in nonculprit lesions responsible for MACE (n=22) versus matched control lesions (n=22). PSS showed marked heterogeneity across and between similar lesions but was significantly increased in MACE lesions at high-risk regions, including plaque burden ≥70% (13.9±11.5 versus 10.2±4.7; P<0.001) and thin-cap fibroatheroma (14.0±8.9 versus 11.6±4.5; P=0.02). Furthermore, PSS improved the ability of virtual-histology intravascular ultrasound to predict MACE in plaques with plaque burden ≥70% (adjusted log-rank, P=0.003) and minimal luminal area ≤4 mm(2) (P=0.002). Plaques responsible for MACE had larger superficial calcium inclusions, which acted to increase PSS (P<0.05).
Baseline PSS is increased in plaques responsible for MACE and improves the ability of intracoronary imaging to predict events. Biomechanical modeling may complement plaque imaging for risk stratification of coronary nonculprit lesions.
尽管斑块破裂是大多数心肌梗死的原因,但通过冠状动脉内成像识别出的高危斑块中,实际上只有少数会导致未来的主要不良心血管事件(MACE)。因此,需要个体斑块行为的非成像标志物。当斑块结构应力(PSS)超过材料强度时就会发生破裂。因此,我们评估了PSS是否能够预测在虚拟组织学血管内超声检查中发现的高危非罪犯病变未来发生的MACE。
在170例行三支血管虚拟组织学血管内超声检查的患者中,确定了与长期随访(中位数:1115天)期间MACE相关的基线非罪犯病变特征。MACE与斑块负荷≥70%(风险比:8.6;95%置信区间,2.5 - 30.6;P<0.001)和最小管腔面积≤4 mm²(风险比:6.6;95%置信区间,2.1 - 20.1;P = 0.036)相关,尽管高危病变的绝对事件发生率仍<10%。随后在导致MACE的非罪犯病变(n = 22)与匹配的对照病变(n = 22)中估计了源自虚拟组织学血管内超声的PSS。PSS在相似病变之间和内部显示出明显的异质性,但在高危区域的MACE病变中显著增加,包括斑块负荷≥70%(13.9±11.5对10.2±4.7;P<0.001)和薄帽纤维粥样斑块(14.0±8.9对11.6±4.5;P = 0.02)。此外,PSS提高了虚拟组织学血管内超声预测斑块负荷≥70%(校正对数秩,P = 0.003)和最小管腔面积≤4 mm²(P = 0.002)的斑块中MACE的能力。导致MACE的斑块有更大的浅表钙包涵体,其作用是增加PSS(P<0.05)。
导致MACE的斑块中基线PSS升高,并且提高了冠状动脉内成像预测事件的能力。生物力学建模可能补充斑块成像用于冠状动脉非罪犯病变的风险分层。